Company Analysis

LifeMD, Inc. (LFMD)

Nasdaq: LFMD · Services-Offices & Clinics of Doctors of Medicine · New York, NY · filing with the SEC since 2012
Grade6.4
◀ Past 5.3● Present 7.1▶ Future 6.4

Filings

304 filings since 2017 beside 237 insider forms · Accelerated filer · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
34661154251527234
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Mar 18, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Aug 21, 2025.SEC letters: 11 in the last 36 months, the newest Feb 14, 2025.A late-filing notice, Form NT 10-Q, filed Nov 9, 2026.A late-filing notice, Form NT 10-Q, filed Nov 12, 2025.
Insider forms 237

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 1.01, 2.02, 2.03, 3.02, 7.01, 9.01 Major agreement signed; Results released; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Nov 9, 2026
Nov 9, 2026 NT 10-Q Late quarterly report notice Sep 30, 2026
Oct 7, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 25, 2026 S-8 Employee stock plan registration
Sep 15, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jul 8, 2026 SCHEDULE 13G Large holder notice
Jun 22, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEFA14A Extra proxy material
Apr 30, 2026 DEF 14A Proxy statement
Apr 1, 2026 S-8 Employee stock plan registration
Mar 18, 2026 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Mar 16, 2026
Mar 10, 2026 10-K Annual report Dec 31, 2025
Mar 9, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jan 6, 2026 8-K items 1.01, 2.03, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Investor disclosure (Regulation FD) · Current report Jan 2, 2026
Nov 17, 2025 10-Q Quarterly report Sep 30, 2025
Nov 17, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 12, 2025 NT 10-Q Late quarterly report notice Sep 30, 2025
Nov 5, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 4, 2025 8-K items 1.01, 2.01, 7.01, 9.01 Major agreement signed; Purchase or sale of a business completed; Investor disclosure (Regulation FD) · Current report
Aug 21, 2025 8-K items 4.01, 9.01 Auditor change · Current report Aug 15, 2025
Aug 5, 2025 10-Q Quarterly report Jun 30, 2025
Aug 5, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 31, 2025 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report
Jun 16, 2025 8-K item 5.07 Shareholder vote · Current report Jun 13, 2025
May 6, 2025 10-Q Quarterly report Mar 31, 2025
May 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 29, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Apr 25, 2025
Apr 28, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 28, 2025 DEFA14A Extra proxy material
Apr 28, 2025 DEF 14A Proxy statement
Apr 25, 2025 8-K items 4.01, 9.01 Auditor change · Current report Apr 24, 2025
Mar 11, 2025 10-K Annual report Dec 31, 2024
Mar 10, 2025 8-K items 2.02, 9.01 Results released · Current report
40 of 304 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton LFMD · research, not advice